Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Why Fellows Should Care about ACR Advocacy

From the College  |  Issue: April 2019  |  April 16, 2019

No More Waiting

Media coverage of healthcare crises often inspires advocacy efforts. But it should not take mainstream media coverage of a crisis to inspire us. Our advocacy efforts should continue day in and day out. Children’s access to care is paramount for pediatric rheumatology. Our field must contend with a shortage of providers and geographic boundaries that may prevent or delay access to a pediatric rheumatologist. Therefore, we must urge for responsible resource allocation as we continue to advocate for our patients. We cannot wait until the next monumental news story to become the voice of our patients. Investments in RheumPAC help physician advocacy efforts translate to lawmakers and policy decisions. As physicians, we cannot remain on the sidelines—politics impact our practice every day. Making an investment as a fellow in training helps lend your voice to these critical issues.

Note: Contributions to RheumPAC are used for political purposes and are not tax deductible. Contributions to RheumPAC must be voluntary and made with personal funds. Federal law prohibits contributions to RheumPAC from corporations, but ask us about the RheumPAC Advocacy Fund, which does support advocacy with soft dollars. Contributions to RheumPAC can be made only by U.S. citizens or permanent resident aliens.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

If you are interested in joining your colleagues in rheumatology advocacy, visit the ACR website to learn more about current policy issues and RheumPAC.


Blaine Lapin, MD, is a current third-year pediatric rheumatology fellow at Baylor College of Medicine, Texas Children’s Hospital. He is the fellow-in-training member of RheumPAC, and he has a special interest in community education and quality of life for patients with chronic disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:RheumPAC

Related Articles

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    Why Fellows Should Care about Advocacy

    March 5, 2019

    As a physician, I am an advocate. I am an advocate for my patients individually and collectively, and I am an advocate for my field: pediatric rheumatology. My own experiences as a patient drive me to integrate my patients’ perspectives into my medical decision making, and although my academic training has prepared me to best…

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences